Hi all,

We have been watching for more news of this since we first read of it, here's the latest info. we have...this is NOT the Neupro patch that was recently recalled but, rather, an actual patch that delivers levadopa....

Israel’s NeuroDerm raises $2.5M for patch-based Parkinson’s drug
David P. Hamilton | July 24th, 2007 |
Israel’s NeuroDerm (the page is currently a placeholder), a biotech developing drug patches for neurological disorders such as Parkinson’s disease, raised $2.5 million in a first round of funding. The investment was provided by private individuals, including Robert Taub, founder and CEO of Omrix Pharmaceuticals.

NeuroDerm, based in Ofakim, Israel, is at work on a skin patch that will allow continuous delivery of levadopa, a drug now used to treat Parkinson’s. Continuous delivery of the drug may help many patients avoid motor complications, the company says.